MyAverix Finance
US · Healthcare
Redhill Biopharma Ltd (RDHL)
Drug Manufacturers - Specialty & Generic
Redhill Biopharma Ltd (RDHL) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for RDHL
Redhill Biopharma Ltd (RDHL) — FAQ
What is RDHL's P/E ratio?
The price-to-earnings (P/E) ratio for Redhill Biopharma Ltd (RDHL) is 18.00 (data as of 2026-05-23).
Does Redhill Biopharma Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Redhill Biopharma Ltd (RDHL). Check the MyAverix Finance app for the latest dividend data.
What sector is Redhill Biopharma Ltd in?
Redhill Biopharma Ltd (RDHL) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is RDHL listed on?
RDHL is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.